{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:01:17Z","timestamp":1792508477327,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":166,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811314346","type":"print"},{"value":"9789811314353","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-13-1435-3_29","type":"book-chapter","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T07:48:45Z","timestamp":1541144925000},"page":"605-624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Muscle Atrophy: Present and Future"],"prefix":"10.1007","author":[{"given":"Richard Y.","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiying","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,3]]},"reference":[{"issue":"1","key":"29_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/emmm.201201443","volume":"5","author":"E Andres-Mateos","year":"2013","unstructured":"Andres-Mateos E, Brinkmeier H, Burks TN, Mejias R, Files DC, Steinberger M, Soleimani A, Marx R, Simmers JL, Lin B, Finanger Hedderick E, Marr TG, Lin BM, Hourde C, Leinwand LA, Kuhl D, Foller M, Vogelsang S, Hernandez-Diaz I, Vaughan DK, Alvarez de la Rosa D, Lang F, Cohn RD (2013) Activation of serum\/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy. EMBO Mol Med 5(1):80\u201391. \nhttps:\/\/doi.org\/10.1002\/emmm.201201443","journal-title":"EMBO Mol Med"},{"issue":"5547","key":"29_CR2","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","volume":"294","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294(5547):1704\u20131708. \nhttps:\/\/doi.org\/10.1126\/science.1065874","journal-title":"Science"},{"issue":"6","key":"29_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.exger.2005.04.003","volume":"40","author":"EE Dupont-Versteegden","year":"2005","unstructured":"Dupont-Versteegden EE (2005) Apoptosis in muscle atrophy: relevance to sarcopenia. Exp Gerontol 40(6):473\u2013481. \nhttps:\/\/doi.org\/10.1016\/j.exger.2005.04.003","journal-title":"Exp Gerontol"},{"key":"29_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.phrs.2015.05.010","volume":"99","author":"V Dutt","year":"2015","unstructured":"Dutt V, Gupta S, Dabur R, Injeti E, Mittal A (2015) Skeletal muscle atrophy: potential therapeutic agents and their mechanisms of action. Pharmacol Res 99:86\u2013100. \nhttps:\/\/doi.org\/10.1016\/j.phrs.2015.05.010","journal-title":"Pharmacol Res"},{"key":"29_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev-med-061509-131248","volume":"62","author":"S Dodson","year":"2011","unstructured":"Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, Dalton JT, Steiner MS (2011) Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 62:265\u2013279. \nhttps:\/\/doi.org\/10.1146\/annurev-med-061509-131248","journal-title":"Annu Rev Med"},{"issue":"1","key":"29_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11005\/jbm.2013.20.1.1","volume":"20","author":"TN Kim","year":"2013","unstructured":"Kim TN, Choi KM (2013) Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab 20(1):1\u201310. \nhttps:\/\/doi.org\/10.11005\/jbm.2013.20.1.1","journal-title":"J Bone Metab"},{"issue":"3","key":"29_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.wem.2017.04.005","volume":"28","author":"T Belli","year":"2017","unstructured":"Belli T, de Macedo DV, Scariot PPM, de Araujo GG, Dos Reis IGM, Lazarim FL, Nunes LAS, Brenzikofer R, Gobatto CA (2017) Glycemic control and muscle damage in 3 athletes with type 1 diabetes during a successful performance in a relay ultramarathon: a case report. Wilderness Environ Med 28(3):239\u2013245. \nhttps:\/\/doi.org\/10.1016\/j.wem.2017.04.005","journal-title":"Wilderness Environ Med"},{"issue":"1","key":"29_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s004210050391","volume":"78","author":"V Oopik","year":"1998","unstructured":"Oopik V, Paasuke M, Timpmann S, Medijainen L, Ereline J, Smirnova T (1998) Effect of creatine supplementation during rapid body mass reduction on metabolism and isokinetic muscle performance capacity. Eur J Appl Physiol Occup Physiol 78(1):83\u201392. \nhttps:\/\/doi.org\/10.1007\/s004210050391","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"29_CR9","doi-asserted-by":"publisher","first-page":"8361237","DOI":"10.1155\/2017\/8361237","volume":"2017","author":"F Wang","year":"2017","unstructured":"Wang F, Wang J, He J, Li W, Li J, Chen S, Zhang P, Liu H, Chen X (2017) Serum miRNAs miR-23a, 206, and 499 as potential biomarkers for skeletal muscle atrophy. Biomed Res Int 2017:8361237. \nhttps:\/\/doi.org\/10.1155\/2017\/8361237","journal-title":"Biomed Res Int"},{"issue":"10","key":"29_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1152\/physiolgenomics.00148.2010","volume":"43","author":"MJ Drummond","year":"2011","unstructured":"Drummond MJ, McCarthy JJ, Sinha M, Spratt HM, Volpi E, Esser KA, Rasmussen BB (2011) Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol Genomics 43(10):595\u2013603. \nhttps:\/\/doi.org\/10.1152\/physiolgenomics.00148.2010","journal-title":"Physiol Genomics"},{"issue":"15","key":"29_CR11","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1101\/gad.263574.115","volume":"29","author":"KP Lee","year":"2015","unstructured":"Lee KP, Shin YJ, Panda AC, Abdelmohsen K, Kim JY, Lee SM, Bahn YJ, Choi JY, Kwon ES, Baek SJ, Kim SY, Gorospe M, Kwon KS (2015) miR-431 promotes differentiation and regeneration of old skeletal muscle by targeting Smad4. Genes Dev 29(15):1605\u20131617. \nhttps:\/\/doi.org\/10.1101\/gad.263574.115","journal-title":"Genes Dev"},{"issue":"32","key":"29_CR12","doi-asserted-by":"publisher","first-page":"21909","DOI":"10.1074\/jbc.M114.561845","volume":"289","author":"RJ Soares","year":"2014","unstructured":"Soares RJ, Cagnin S, Chemello F, Silvestrin M, Musaro A, De Pitta C, Lanfranchi G, Sandri M (2014) Involvement of microRNAs in the regulation of muscle wasting during catabolic conditions. J Biol Chem 289(32):21909\u201321925. \nhttps:\/\/doi.org\/10.1074\/jbc.M114.561845","journal-title":"J Biol Chem"},{"issue":"9","key":"29_CR13","doi-asserted-by":"publisher","first-page":"6663","DOI":"10.1074\/jbc.M112.390369","volume":"288","author":"H Kukreti","year":"2013","unstructured":"Kukreti H, Amuthavalli K, Harikumar A, Sathiyamoorthy S, Feng PZ, Anantharaj R, Tan SL, Lokireddy S, Bonala S, Sriram S, McFarlane C, Kambadur R, Sharma M (2013) Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy. J Biol Chem 288(9):6663\u20136678. \nhttps:\/\/doi.org\/10.1074\/jbc.M112.390369","journal-title":"J Biol Chem"},{"key":"29_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2474-11-181","volume":"11","author":"CS Rau","year":"2010","unstructured":"Rau CS, Jeng JC, Jeng SF, Lu TH, Chen YC, Liliang PC, Wu CJ, Lin CJ, Hsieh CH (2010) Entrapment neuropathy results in different microRNA expression patterns from denervation injury in rats. BMC Musculoskelet Disord 11:181. \nhttps:\/\/doi.org\/10.1186\/1471-2474-11-181","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"29_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/apha.12819","volume":"220","author":"AP Russell","year":"2017","unstructured":"Russell AP, Wallace MA, Kalanon M, Zacharewicz E, Della Gatta PA, Garnham A, Lamon S (2017) Striated muscle activator of Rho signalling (STARS) is reduced in ageing human skeletal muscle and targeted by miR-628-5p. Acta Physiol (Oxf) 220(2):263\u2013274. \nhttps:\/\/doi.org\/10.1111\/apha.12819","journal-title":"Acta Physiol (Oxf)"},{"issue":"10","key":"29_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4149\/BLL_2017_121","volume":"118","author":"SZ Zhang","year":"2017","unstructured":"Zhang SZ, Cai L, Li B (2017) MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma. Bratisl Lek Listy 118(10):632\u2013636. \nhttps:\/\/doi.org\/10.4149\/BLL_2017_121","journal-title":"Bratisl Lek Listy"},{"issue":"1","key":"29_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, Wang B (2018) Exosome theranostics: biology and translational medicine. Theranostics 8(1):237\u2013255. \nhttps:\/\/doi.org\/10.7150\/thno.21945","journal-title":"Theranostics"},{"issue":"6","key":"29_CR18","doi-asserted-by":"publisher","first-page":"C551","DOI":"10.1152\/ajpcell.00266.2013","volume":"306","author":"MB Hudson","year":"2014","unstructured":"Hudson MB, Woodworth-Hobbs ME, Zheng B, Rahnert JA, Blount MA, Gooch JL, Searles CD, Price SR (2014) miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export. Am J Physiol Cell Physiol 306(6):C551\u2013C558. \nhttps:\/\/doi.org\/10.1152\/ajpcell.00266.2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"29_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fnut.2017.00069","volume":"4","author":"R Marinho","year":"2017","unstructured":"Marinho R, Alcantara PSM, Ottoch JP, Seelaender M (2017) Role of exosomal MicroRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting. Front Nutr 4:69. \nhttps:\/\/doi.org\/10.3389\/fnut.2017.00069","journal-title":"Front Nutr"},{"issue":"17","key":"29_CR20","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1093\/hmg\/ddx212","volume":"26","author":"A Koutsoulidou","year":"2017","unstructured":"Koutsoulidou A, Photiades M, Kyriakides TC, Georgiou K, Prokopi M, Kapnisis K, Lusakowska A, Nearchou M, Christou Y, Papadimas GK, Anayiotos A, Kyriakou K, Kararizou E, Zamba Papanicolaou E, Phylactou LA (2017) Identification of exosomal muscle-specific miRNAs in serum of myotonic dystrophy patients relating to muscle disease progress. Hum Mol Genet 26(17):3285\u20133302. \nhttps:\/\/doi.org\/10.1093\/hmg\/ddx212","journal-title":"Hum Mol Genet"},{"key":"29_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Thery C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255\u2013289. \nhttps:\/\/doi.org\/10.1146\/annurev-cellbio-101512-122326","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"11","key":"29_CR22","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I (2014) Ubiquitination in disease pathogenesis and treatment. Nat Med 20(11):1242\u20131253. \nhttps:\/\/doi.org\/10.1038\/nm.3739","journal-title":"Nat Med"},{"issue":"6","key":"29_CR23","doi-asserted-by":"publisher","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","volume":"307","author":"SC Bodine","year":"2014","unstructured":"Bodine SC, Baehr LM (2014) Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1. Am J Physiol Endocrinol Metab 307(6):E469\u2013E484. \nhttps:\/\/doi.org\/10.1152\/ajpendo.00204.2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"29_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1083\/jcb.201110067","volume":"198","author":"S Cohen","year":"2012","unstructured":"Cohen S, Zhai B, Gygi SP, Goldberg AL (2012) Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy. J Cell Biol 198(4):575\u2013589. \nhttps:\/\/doi.org\/10.1083\/jcb.201110067","journal-title":"J Cell Biol"},{"issue":"3","key":"29_CR25","doi-asserted-by":"publisher","first-page":"C392","DOI":"10.1152\/ajpcell.00125.2016","volume":"311","author":"PA Bilodeau","year":"2016","unstructured":"Bilodeau PA, Coyne ES, Wing SS (2016) The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation. Am J Physiol Cell Physiol 311(3):C392\u2013C403. \nhttps:\/\/doi.org\/10.1152\/ajpcell.00125.2016","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"29_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrd4467","volume":"14","author":"S Cohen","year":"2015","unstructured":"Cohen S, Nathan JA, Goldberg AL (2015) Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov 14(1):58\u201374. \nhttps:\/\/doi.org\/10.1038\/nrd4467","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"29_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ncb1101-1009","volume":"3","author":"C Rommel","year":"2001","unstructured":"Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways. Nat Cell Biol 3(11):1009\u20131013. \nhttps:\/\/doi.org\/10.1038\/ncb1101-1009","journal-title":"Nat Cell Biol"},{"issue":"3","key":"29_CR28","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ijcard.2014.08.086","volume":"176","author":"S Palus","year":"2014","unstructured":"Palus S, von Haehling S, Springer J (2014) Muscle wasting: an overview of recent developments in basic research. Int J Cardiol 176(3):640\u2013644. \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2014.08.086","journal-title":"Int J Cardiol"},{"key":"29_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev-pharmtox-010510-100537","volume":"51","author":"MA Ruegg","year":"2011","unstructured":"Ruegg MA, Glass DJ (2011) Molecular mechanisms and treatment options for muscle wasting diseases. Annu Rev Pharmacol Toxicol 51:373\u2013395. \nhttps:\/\/doi.org\/10.1146\/annurev-pharmtox-010510-100537","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"29_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","volume":"98","author":"F Haddad","year":"1985","unstructured":"Haddad F, Zaldivar F, Cooper DM (1985) Adams GR (2005) IL-6-induced skeletal muscle atrophy. J Appl Physiol 98(3):911\u2013917. \nhttps:\/\/doi.org\/10.1152\/japplphysiol.01026.2004","journal-title":"J Appl Physiol"},{"issue":"4","key":"29_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1748-1716.2011.02281.x","volume":"202","author":"TA Washington","year":"2011","unstructured":"Washington TA, White JP, Davis JM, Wilson LB, Lowe LL, Sato S, Carson JA (2011) Skeletal muscle mass recovery from atrophy in IL-6 knockout mice. Acta Physiol (Oxf) 202(4):657\u2013669. \nhttps:\/\/doi.org\/10.1111\/j.1748-1716.2011.02281.x","journal-title":"Acta Physiol (Oxf)"},{"issue":"3","key":"29_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017392","volume":"6","author":"KG Toth","year":"2011","unstructured":"Toth KG, McKay BR, De Lisio M, Little JP, Tarnopolsky MA, Parise G (2011) IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage. PLoS One 6(3):e17392. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0017392","journal-title":"PLoS One"},{"issue":"2","key":"29_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","volume":"119","author":"D Cai","year":"2004","unstructured":"Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE (2004) IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice. Cell 119(2):285\u2013298. \nhttps:\/\/doi.org\/10.1016\/j.cell.2004.09.027","journal-title":"Cell"},{"issue":"6","key":"29_CR34","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1083\/jcb.200207056","volume":"162","author":"S McCroskery","year":"2003","unstructured":"McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R (2003) Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162(6):1135\u20131147. \nhttps:\/\/doi.org\/10.1083\/jcb.200207056","journal-title":"J Cell Biol"},{"issue":"7","key":"29_CR35","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1073\/pnas.0408729102","volume":"102","author":"KR Wagner","year":"2005","unstructured":"Wagner KR, Liu X, Chang X, Allen RE (2005) Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci U S A 102(7):2519\u20132524. \nhttps:\/\/doi.org\/10.1073\/pnas.0408729102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"29_CR36","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1249\/MSS.0b013e3181e0b9a8","volume":"42","author":"DS Hittel","year":"2010","unstructured":"Hittel DS, Axelson M, Sarna N, Shearer J, Huffman KM, Kraus WE (2010) Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc 42(11):2023\u20132029. \nhttps:\/\/doi.org\/10.1249\/MSS.0b013e3181e0b9a8","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"29_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/oby.20070","volume":"21","author":"R Watts","year":"2013","unstructured":"Watts R, McAinch AJ, Dixon JB, O\u2019Brien PE, Cameron-Smith D (2013) Increased Smad signaling and reduced MRF expression in skeletal muscle from obese subjects. Obesity (Silver Spring) 21(3):525\u2013528. \nhttps:\/\/doi.org\/10.1002\/oby.20070","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"29_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s002280050172","volume":"51","author":"M Sigmund","year":"1996","unstructured":"Sigmund M, Jakob H, Becker H, Hanrath P, Schumacher C, Eschenhagen T, Schmitz W, Scholz H, Steinfath M (1996) Effects of metoprolol on myocardial beta-adrenoceptors and Gi alpha-proteins in patients with congestive heart failure. Eur J Clin Pharmacol 51(2):127\u2013132","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"29_CR39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00210-003-0754-z","volume":"367","author":"K Ponicke","year":"2003","unstructured":"Ponicke K, Heinroth-Hoffmann I, Brodde OE (2003) Role of beta 1- and beta 2-adrenoceptors in hypertrophic and apoptotic effects of noradrenaline and adrenaline in adult rat ventricular cardiomyocytes. Naunyn Schmiedeberg's Arch Pharmacol 367(6):592\u2013599. \nhttps:\/\/doi.org\/10.1007\/s00210-003-0754-z","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"6","key":"29_CR40","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/jcmm.12253","volume":"18","author":"VA Voltarelli","year":"2014","unstructured":"Voltarelli VA, Bechara LR, Bacurau AV, Mattos KC, Dourado PM, Bueno CR Jr, Casarini DE, Negrao CE, Brum PC (2014) Lack of beta2 -adrenoceptors aggravates heart failure-induced skeletal muscle myopathy in mice. J Cell Mol Med 18(6):1087\u20131097. \nhttps:\/\/doi.org\/10.1111\/jcmm.12253","journal-title":"J Cell Mol Med"},{"key":"29_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbpa.2017.05.013","volume":"211","author":"S Shimamoto","year":"2017","unstructured":"Shimamoto S, Ijiri D, Kawaguchi M, Nakashima K, Tada O, Inoue H, Ohtsuka A (2017) beta1- and beta2-adrenergic receptor stimulation differ in their effects on PGC-1alpha and atrogin-1\/MAFbx gene expression in chick skeletal muscle. Comp Biochem Physiol A Mol Integr Physiol 211:1\u20136. \nhttps:\/\/doi.org\/10.1016\/j.cbpa.2017.05.013","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"issue":"8","key":"29_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00109-016-1443-y","volume":"94","author":"A Simionescu-Bankston","year":"2016","unstructured":"Simionescu-Bankston A, Kumar A (2016) Noncoding RNAs in the regulation of skeletal muscle biology in health and disease. J Mol Med (Berl) 94(8):853\u2013866. \nhttps:\/\/doi.org\/10.1007\/s00109-016-1443-y","journal-title":"J Mol Med (Berl)"},{"issue":"11","key":"29_CR43","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/gerona\/glx025","volume":"72","author":"HJ Jung","year":"2017","unstructured":"Jung HJ, Lee KP, Milholland B, Shin YJ, Kang JS, Kwon KS, Suh Y (2017) Comprehensive miRNA profiling of skeletal muscle and serum in induced and normal mouse muscle atrophy during aging. J Gerontol A Biol Sci Med Sci 72(11):1483\u20131491. \nhttps:\/\/doi.org\/10.1093\/gerona\/glx025","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"29_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/wrna.1227","volume":"5","author":"A Kovanda","year":"2014","unstructured":"Kovanda A, Rezen T, Rogelj B (2014) MicroRNA in skeletal muscle development, growth, atrophy, and disease. Wiley Interdiscip Rev RNA 5(4):509\u2013525. \nhttps:\/\/doi.org\/10.1002\/wrna.1227","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"29_CR45","first-page":"397","volume":"41","author":"V Swaminathan","year":"2007","unstructured":"Swaminathan V, Reddy BA, Ruthrotha Selvi B, Sukanya MS, Kundu TK (2007) Small molecule modulators in epigenetics: implications in gene expression and therapeutics. Subcell Biochem 41:397\u2013428","journal-title":"Subcell Biochem"},{"issue":"7","key":"29_CR46","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/jcp.25260","volume":"231","author":"J Fan","year":"2016","unstructured":"Fan J, Kou X, Jia S, Yang X, Yang Y, Chen N (2016) Autophagy as a potential target for sarcopenia. J Cell Physiol 231(7):1450\u20131459. \nhttps:\/\/doi.org\/10.1002\/jcp.25260","journal-title":"J Cell Physiol"},{"issue":"6","key":"29_CR47","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cmet.2017.09.020","volume":"26","author":"N Martinez-Lopez","year":"2017","unstructured":"Martinez-Lopez N, Tarabra E, Toledo M, Garcia-Macia M, Sahu S, Coletto L, Batista-Gonzalez A, Barzilai N, Pessin JE, Schwartz GJ, Kersten S, Singh R (2017) System-wide benefits of intermeal fasting by autophagy. Cell Metab 26(6):856\u2013871 e855. \nhttps:\/\/doi.org\/10.1016\/j.cmet.2017.09.020","journal-title":"Cell Metab"},{"issue":"6 Suppl","key":"29_CR48","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/1097-0142(20010915)92:6+<1669::AID-CNCR1495>3.0.CO;2-S","volume":"92","author":"VE Baracos","year":"2001","unstructured":"Baracos VE (2001) Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies. Cancer 92(6 Suppl):1669\u20131677","journal-title":"Cancer"},{"issue":"3","key":"29_CR49","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/ajcn\/66.3.683","volume":"66","author":"S Klein","year":"1997","unstructured":"Klein S, Kinney J, Jeejeebhoy K, Alpers D, Hellerstein M, Murray M, Twomey P (1997) Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 66(3):683\u2013706","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"29_CR50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","volume":"14","author":"S Haehling von","year":"2017","unstructured":"von Haehling S, Ebner N, Dos Santos MR, Springer J, Anker SD (2017) Muscle wasting and cachexia in heart failure: mechanisms and therapies. Nat Rev Cardiol 14(6):323\u2013341. \nhttps:\/\/doi.org\/10.1038\/nrcardio.2017.51","journal-title":"Nat Rev Cardiol"},{"key":"29_CR51","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2147\/CIA.S49810","volume":"8","author":"RE Valenzuela","year":"2013","unstructured":"Valenzuela RE, Ponce JA, Morales-Figueroa GG, Muro KA, Carreon VR, Aleman-Mateo H (2013) Insufficient amounts and inadequate distribution of dietary protein intake in apparently healthy older adults in a developing country: implications for dietary strategies to prevent sarcopenia. Clin Interv Aging 8:1143\u20131148. \nhttps:\/\/doi.org\/10.2147\/CIA.S49810","journal-title":"Clin Interv Aging"},{"issue":"11","key":"29_CR52","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.ejheart.2008.09.002","volume":"10","author":"R Aquilani","year":"2008","unstructured":"Aquilani R, Opasich C, Gualco A, Verri M, Testa A, Pasini E, Viglio S, Iadarola P, Pastoris O, Dossena M, Boschi F (2008) Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure. Eur J Heart Fail 10(11):1127\u20131135. \nhttps:\/\/doi.org\/10.1016\/j.ejheart.2008.09.002","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"29_CR53","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.2040-1124.2010.00046.x","volume":"1","author":"A Nakamura","year":"2010","unstructured":"Nakamura A, Osonoi T, Terauchi Y (2010) Relationship between urinary sodium excretion and pioglitazone-induced edema. J Diabetes Investig 1(5):208\u2013211. \nhttps:\/\/doi.org\/10.1111\/j.2040-1124.2010.00046.x","journal-title":"J Diabetes Investig"},{"issue":"4","key":"29_CR54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0002-9610(02)00823-1","volume":"183","author":"PE May","year":"2002","unstructured":"May PE, Barber A, D\u2019Olimpio JT, Hourihane A, Abumrad NN (2002) Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 183(4):471\u2013479","journal-title":"Am J Surg"},{"issue":"3","key":"29_CR55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/0148607100024003133","volume":"24","author":"RH Clark","year":"2000","unstructured":"Clark RH, Feleke G, Din M, Yasmin T, Singh G, Khan FA, Rathmacher JA (2000) Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. JPEN J Parenter Enteral Nutr 24(3):133\u2013139. \nhttps:\/\/doi.org\/10.1177\/0148607100024003133","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"29_CR56","first-page":"544","volume":"15","author":"LC Hsieh","year":"2006","unstructured":"Hsieh LC, Chien SL, Huang MS, Tseng HF, Chang CK (2006) Anti-inflammatory and anticatabolic effects of short-term beta-hydroxy-beta-methylbutyrate supplementation on chronic obstructive pulmonary disease patients in intensive care unit. Asia Pac J Clin Nutr 15(4):544\u2013550","journal-title":"Asia Pac J Clin Nutr"},{"issue":"1","key":"29_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/0148607108322403","volume":"33","author":"S Baier","year":"2009","unstructured":"Baier S, Johannsen D, Abumrad N, Rathmacher JA, Nissen S, Flakoll P (2009) Year-long changes in protein metabolism in elderly men and women supplemented with a nutrition cocktail of beta-hydroxy-beta-methylbutyrate (HMB), L-arginine, and L-lysine. JPEN J Parenter Enteral Nutr 33(1):71\u201382. \nhttps:\/\/doi.org\/10.1177\/0148607108322403","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"5","key":"29_CR58","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.clnu.2013.02.011","volume":"32","author":"NE Deutz","year":"2013","unstructured":"Deutz NE, Pereira SL, Hays NP, Oliver JS, Edens NK, Evans CM, Wolfe RR (2013) Effect of beta-hydroxy-beta-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults. Clin Nutr 32(5):704\u2013712. \nhttps:\/\/doi.org\/10.1016\/j.clnu.2013.02.011","journal-title":"Clin Nutr"},{"issue":"9","key":"29_CR59","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.exger.2013.06.005","volume":"48","author":"SE Alway","year":"2013","unstructured":"Alway SE, Pereira SL, Edens NK, Hao Y, Bennett BT (2013) beta-Hydroxy-beta-methylbutyrate (HMB) enhances the proliferation of satellite cells in fast muscles of aged rats during recovery from disuse atrophy. Exp Gerontol 48(9):973\u2013984. \nhttps:\/\/doi.org\/10.1016\/j.exger.2013.06.005","journal-title":"Exp Gerontol"},{"key":"29_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1743-7075-11-23","volume":"11","author":"JJ Meidenbauer","year":"2014","unstructured":"Meidenbauer JJ, Ta N, Seyfried TN (2014) Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL\/6J mice. Nutr Metab (Lond) 11:23. \nhttps:\/\/doi.org\/10.1186\/1743-7075-11-23","journal-title":"Nutr Metab (Lond)"},{"issue":"13","key":"29_CR61","doi-asserted-by":"publisher","first-page":"21778","DOI":"10.18632\/oncotarget.15583","volume":"8","author":"A Camperi","year":"2017","unstructured":"Camperi A, Pin F, Costamagna D, Penna F, Menduina ML, Aversa Z, Zimmers T, Verzaro R, Fittipaldi R, Caretti G, Baccino FM, Muscaritoli M, Costelli P (2017) Vitamin D and VDR in cancer cachexia and muscle regeneration. Oncotarget 8(13):21778\u201321793. \nhttps:\/\/doi.org\/10.18632\/oncotarget.15583","journal-title":"Oncotarget"},{"issue":"3","key":"29_CR62","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/ageing\/aft046","volume":"42","author":"LA Beveridge","year":"2013","unstructured":"Beveridge LA, Ramage L, McMurdo ME, George J, Witham MD (2013) Allopurinol use is associated with greater functional gains in older rehabilitation patients. Age Ageing 42(3):400\u2013404. \nhttps:\/\/doi.org\/10.1093\/ageing\/aft046","journal-title":"Age Ageing"},{"issue":"10","key":"29_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046668","volume":"7","author":"F Derbre","year":"2012","unstructured":"Derbre F, Ferrando B, Gomez-Cabrera MC, Sanchis-Gomar F, Martinez-Bello VE, Olaso-Gonzalez G, Diaz A, Gratas-Delamarche A, Cerda M, Vina J (2012) Inhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligases. PLoS One 7(10):e46668. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0046668","journal-title":"PLoS One"},{"issue":"7","key":"29_CR64","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1249\/MSS.0b013e318213fefb","volume":"43","author":"CE Garber","year":"2011","unstructured":"Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP, American College of Sports Medicine (2011) American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43(7):1334\u20131359. \nhttps:\/\/doi.org\/10.1249\/MSS.0b013e318213fefb","journal-title":"Med Sci Sports Exerc"},{"issue":"8","key":"29_CR65","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the D, Treatment of A, Chronic Heart Failure of the European Society of C, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, Guidelines ESCCfP (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14(8):803\u2013869. \nhttps:\/\/doi.org\/10.1093\/eurjhf\/hfs105","journal-title":"Eur J Heart Fail"},{"key":"29_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00399","volume":"6","author":"T Pietrangelo","year":"2015","unstructured":"Pietrangelo T, Di Filippo ES, Mancinelli R, Doria C, Rotini A, Fano-Illic G, Fulle S (2015) Low intensity exercise training improves skeletal muscle regeneration potential. Front Physiol 6:399. \nhttps:\/\/doi.org\/10.3389\/fphys.2015.00399","journal-title":"Front Physiol"},{"issue":"3","key":"29_CR67","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/stem.2281","volume":"34","author":"A Galimov","year":"2016","unstructured":"Galimov A, Merry TL, Luca E, Rushing EJ, Mizbani A, Turcekova K, Hartung A, Croce CM, Ristow M, Krutzfeldt J (2016) MicroRNA-29a in adult muscle stem cells controls skeletal muscle regeneration during injury and exercise downstream of fibroblast growth factor-2. Stem Cells 34(3):768\u2013780. \nhttps:\/\/doi.org\/10.1002\/stem.2281","journal-title":"Stem Cells"},{"issue":"3","key":"29_CR68","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.ijcard.2012.03.083","volume":"167","author":"R Hollriegel","year":"2013","unstructured":"Hollriegel R, Beck EB, Linke A, Adams V, Mobius-Winkler S, Mangner N, Sandri M, Gielen S, Gutberlet M, Hambrecht R, Schuler G, Erbs S (2013) Anabolic effects of exercise training in patients with advanced chronic heart failure (NYHA IIIb): impact on ubiquitin-protein ligases expression and skeletal muscle size. Int J Cardiol 167(3):975\u2013980. \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2012.03.083","journal-title":"Int J Cardiol"},{"issue":"3","key":"29_CR69","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1741826711402735","volume":"19","author":"K Lenk","year":"2012","unstructured":"Lenk K, Erbs S, Hollriegel R, Beck E, Linke A, Gielen S, Winkler SM, Sandri M, Hambrecht R, Schuler G, Adams V (2012) Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol 19(3):404\u2013411. \nhttps:\/\/doi.org\/10.1177\/1741826711402735","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"29_CR70","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13539-011-0047-1","volume":"3","author":"MJ Puppa","year":"2012","unstructured":"Puppa MJ, White JP, Velazquez KT, Baltgalvis KA, Sato S, Baynes JW, Carson JA (2012) The effect of exercise on IL-6-induced cachexia in the Apc ( Min\/+) mouse. J Cachexia Sarcopenia Muscle 3(2):117\u2013137. \nhttps:\/\/doi.org\/10.1007\/s13539-011-0047-1","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"29_CR71","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cyto.2012.10.021","volume":"61","author":"FF Donatto","year":"2013","unstructured":"Donatto FF, Neves RX, Rosa FO, Camargo RG, Ribeiro H, Matos-Neto EM, Seelaender M (2013) Resistance exercise modulates lipid plasma profile and cytokine content in the adipose tissue of tumour-bearing rats. Cytokine 61(2):426\u2013432. \nhttps:\/\/doi.org\/10.1016\/j.cyto.2012.10.021","journal-title":"Cytokine"},{"issue":"4","key":"29_CR72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/SPC.0000000000000170","volume":"9","author":"FS Lira","year":"2015","unstructured":"Lira FS, Antunes Bde M, Seelaender M, Rosa Neto JC (2015) The therapeutic potential of exercise to treat cachexia. Curr Opin Support Palliat Care 9(4):317\u2013324. \nhttps:\/\/doi.org\/10.1097\/SPC.0000000000000170","journal-title":"Curr Opin Support Palliat Care"},{"key":"29_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/srep26991","volume":"6","author":"E Pigna","year":"2016","unstructured":"Pigna E, Berardi E, Aulino P, Rizzuto E, Zampieri S, Carraro U, Kern H, Merigliano S, Gruppo M, Mericskay M, Li Z, Rocchi M, Barone R, Macaluso F, Di Felice V, Adamo S, Coletti D, Moresi V (2016) Aerobic exercise and pharmacological treatments counteract cachexia by modulating autophagy in colon cancer. Sci Rep 6:26991. \nhttps:\/\/doi.org\/10.1038\/srep26991","journal-title":"Sci Rep"},{"issue":"41","key":"29_CR74","doi-asserted-by":"publisher","first-page":"43202","DOI":"10.18632\/oncotarget.6439","volume":"6","author":"F Pin","year":"2015","unstructured":"Pin F, Busquets S, Toledo M, Camperi A, Lopez-Soriano FJ, Costelli P, Argiles JM, Penna F (2015) Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations. Oncotarget 6(41):43202\u201343215. \nhttps:\/\/doi.org\/10.18632\/oncotarget.6439","journal-title":"Oncotarget"},{"issue":"4","key":"29_CR75","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/gut.2004.047563","volume":"54","author":"JN Gordon","year":"2005","unstructured":"Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM (2005) Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 54(4):540\u2013545. \nhttps:\/\/doi.org\/10.1136\/gut.2004.047563","journal-title":"Gut"},{"key":"29_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-2197-2","volume":"5","author":"JE Belizario","year":"2016","unstructured":"Belizario JE, Fontes-Oliveira CC, Borges JP, Kashiabara JA, Vannier E (2016) Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6. Springerplus 5:619. \nhttps:\/\/doi.org\/10.1186\/s40064-016-2197-2","journal-title":"Springerplus"},{"issue":"5","key":"29_CR77","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/1055-9965.EPI-05-0538","volume":"15","author":"G Mantovani","year":"2006","unstructured":"Mantovani G, Maccio A, Madeddu C, Gramignano G, Lusso MR, Serpe R, Massa E, Astara G, Deiana L (2006) A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia\/cachexia and oxidative stress. Cancer Epidemiol Biomark Prev 15(5):1030\u20131034. \nhttps:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0538","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"29_CR78","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ghir.2008.12.003","volume":"19","author":"JM Garcia","year":"2009","unstructured":"Garcia JM, Polvino WJ (2009) Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers. Growth Hormon IGF Res 19(3):267\u2013273. \nhttps:\/\/doi.org\/10.1016\/j.ghir.2008.12.003","journal-title":"Growth Hormon IGF Res"},{"issue":"1","key":"29_CR79","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00109-009-0547-z","volume":"88","author":"G Mantovani","year":"2010","unstructured":"Mantovani G, Maccio A, Madeddu C, Serpe R, Antoni G, Massa E, Dessi M, Panzone F (2010) Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia. J Mol Med (Berl) 88(1):85\u201392. \nhttps:\/\/doi.org\/10.1007\/s00109-009-0547-z","journal-title":"J Mol Med (Berl)"},{"issue":"7","key":"29_CR80","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00432-013-1412-6","volume":"139","author":"L Zhang","year":"2013","unstructured":"Zhang L, Tang H, Kou Y, Li R, Zheng Y, Wang Q, Zhou X, Jin L (2013) MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia. J Cancer Res Clin Oncol 139(7):1105\u20131115. \nhttps:\/\/doi.org\/10.1007\/s00432-013-1412-6","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"29_CR81","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","volume":"391","author":"ME Benny Klimek","year":"2010","unstructured":"Benny Klimek ME, Aydogdu T, Link MJ, Pons M, Koniaris LG, Zimmers TA (2010) Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun 391(3):1548\u20131554. \nhttps:\/\/doi.org\/10.1016\/j.bbrc.2009.12.123","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"29_CR82","doi-asserted-by":"publisher","first-page":"R716","DOI":"10.1152\/ajpregu.00121.2011","volume":"301","author":"KT Murphy","year":"2011","unstructured":"Murphy KT, Chee A, Gleeson BG, Naim T, Swiderski K, Koopman R, Lynch GS (2011) Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice. Am J Phys Regul Integr Comp Phys 301(3):R716\u2013R726. \nhttps:\/\/doi.org\/10.1152\/ajpregu.00121.2011","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"3","key":"29_CR83","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.109.882068","volume":"121","author":"J Heineke","year":"2010","unstructured":"Heineke J, Auger-Messier M, Xu J, Sargent M, York A, Welle S, Molkentin JD (2010) Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation 121(3):419\u2013425. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.882068","journal-title":"Circulation"},{"issue":"3","key":"29_CR84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0167-5273(00)00233-3","volume":"73","author":"D Harrington","year":"2000","unstructured":"Harrington D, Chua TP, Coats AJ (2000) The effect of salbutamol on skeletal muscle in chronic heart failure. Int J Cardiol 73(3):257\u2013265","journal-title":"Int J Cardiol"},{"issue":"4","key":"29_CR85","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.healun.2008.01.013","volume":"27","author":"G Kamalakkannan","year":"2008","unstructured":"Kamalakkannan G, Petrilli CM, George I, LaManca J, McLaughlin BT, Shane E, Mancini DM, Maybaum S (2008) Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure. J Heart Lung Transplant 27(4):457\u2013461. \nhttps:\/\/doi.org\/10.1016\/j.healun.2008.01.013","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"29_CR86","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cardfail.2008.12.011","volume":"15","author":"EA Jankowska","year":"2009","unstructured":"Jankowska EA, Filippatos G, Ponikowska B, Borodulin-Nadzieja L, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P (2009) Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J Card Fail 15(5):442\u2013450. \nhttps:\/\/doi.org\/10.1016\/j.cardfail.2008.12.011","journal-title":"J Card Fail"},{"issue":"10","key":"29_CR87","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacc.2009.04.078","volume":"54","author":"G Caminiti","year":"2009","unstructured":"Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C, Piepoli M, Fini M, Rosano GM (2009) Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 54(10):919\u2013927. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2009.04.078","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"29_CR88","doi-asserted-by":"publisher","first-page":"615","DOI":"10.11909\/j.issn.1671-5411.2016.07.004","volume":"13","author":"A Collamati","year":"2016","unstructured":"Collamati A, Marzetti E, Calvani R, Tosato M, D\u2019Angelo E, Sisto AN, Landi F (2016) Sarcopenia in heart failure: mechanisms and therapeutic strategies. J Geriatr Cardiol 13(7):615\u2013624. \nhttps:\/\/doi.org\/10.11909\/j.issn.1671-5411.2016.07.004","journal-title":"J Geriatr Cardiol"},{"issue":"24","key":"29_CR89","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","volume":"110","author":"N Nagaya","year":"2004","unstructured":"Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, Ueno K, Kitakaze M, Miyatake K, Kangawa K (2004) Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110(24):3674\u20133679. \nhttps:\/\/doi.org\/10.1161\/01.CIR.0000149746.62908.BB","journal-title":"Circulation"},{"issue":"1","key":"29_CR90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13539-011-0020-z","volume":"2","author":"T Kung","year":"2011","unstructured":"Kung T, Szabo T, Springer J, Doehner W, Anker SD, von Haehling S (2011) Cachexia in heart disease: highlights from the ESC 2010. J Cachexia Sarcopenia Muscle 2(1):63\u201369. \nhttps:\/\/doi.org\/10.1007\/s13539-011-0020-z","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"29_CR91","doi-asserted-by":"publisher","first-page":"888","DOI":"10.2337\/db11-1073","volume":"61","author":"W Chai","year":"2012","unstructured":"Chai W, Dong Z, Wang N, Wang W, Tao L, Cao W, Liu Z (2012) Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism. Diabetes 61(4):888\u2013896. \nhttps:\/\/doi.org\/10.2337\/db11-1073","journal-title":"Diabetes"},{"issue":"9","key":"29_CR92","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/qjmed\/hcp093","volume":"102","author":"D Scott","year":"2009","unstructured":"Scott D, Blizzard L, Fell J, Jones G (2009) Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM 102(9):625\u2013633. \nhttps:\/\/doi.org\/10.1093\/qjmed\/hcp093","journal-title":"QJM"},{"issue":"1\u20132","key":"29_CR93","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.drudis.2007.10.008","volume":"13","author":"JM Argiles","year":"2008","unstructured":"Argiles JM, Lopez-Soriano FJ, Busquets S (2008) Novel approaches to the treatment of cachexia. Drug Discov Today 13(1\u20132):73\u201378. \nhttps:\/\/doi.org\/10.1016\/j.drudis.2007.10.008","journal-title":"Drug Discov Today"},{"issue":"4","key":"29_CR94","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1152\/japplphysiol.01183.2010","volume":"110","author":"KT Murphy","year":"2011","unstructured":"Murphy KT, Cobani V, Ryall JG, Ibebunjo C, Lynch GS (2011) Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice. J Appl Physiol 110(4):1065\u20131072. \nhttps:\/\/doi.org\/10.1152\/japplphysiol.01183.2010","journal-title":"J Appl Physiol"},{"issue":"5","key":"29_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035708","volume":"7","author":"K Miki","year":"2012","unstructured":"Miki K, Maekura R, Nagaya N, Nakazato M, Kimura H, Murakami S, Ohnishi S, Hiraga T, Miki M, Kitada S, Yoshimura K, Tateishi Y, Arimura Y, Matsumoto N, Yoshikawa M, Yamahara K, Kangawa K (2012) Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS One 7(5):e35708. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0035708","journal-title":"PLoS One"},{"issue":"3","key":"29_CR96","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ijcard.2010.05.042","volume":"144","author":"S Haehling von","year":"2010","unstructured":"von Haehling S, Stepney R, Anker SD (2010) Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference. Int J Cardiol 144(3):347\u2013349. \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2010.05.042","journal-title":"Int J Cardiol"},{"issue":"5","key":"29_CR97","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/j.clnme.2012.07.004","volume":"7","author":"Benjamin Levinson","year":"2012","unstructured":"Levinson B, Gertner J (2012) Randomized study of the efficacy and safety of SUN11031 (synthetic human ghrelin) in cachexia associated with chronic obstructive pulmonary disease. e-SPEN J 7(5):e171\u2013e175. \nhttps:\/\/doi.org\/10.1016\/j.clnme.2012.07.004","journal-title":"e-SPEN Journal"},{"issue":"9","key":"29_CR98","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1164\/rccm.200310-1465OC","volume":"169","author":"C Koechlin","year":"2004","unstructured":"Koechlin C, Couillard A, Simar D, Cristol JP, Bellet H, Hayot M, Prefaut C (2004) Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 169(9):1022\u20131027. \nhttps:\/\/doi.org\/10.1164\/rccm.200310-1465OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"29_CR99","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1249\/MSS.0b013e3182846d7e","volume":"45","author":"MJ Rossman","year":"2013","unstructured":"Rossman MJ, Groot HJ, Reese V, Zhao J, Amann M, Richardson RS (2013) Oxidative stress and COPD: the effect of oral antioxidants on skeletal muscle fatigue. Med Sci Sports Exerc 45(7):1235\u20131243. \nhttps:\/\/doi.org\/10.1249\/MSS.0b013e3182846d7e","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"29_CR100","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1096\/fj.10-176917","volume":"25","author":"L Zhang","year":"2011","unstructured":"Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, Song Y, Min H, Wang X, Du J, Mitch WE (2011) Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J 25(5):1653\u20131663. \nhttps:\/\/doi.org\/10.1096\/fj.10-176917","journal-title":"FASEB J"},{"issue":"3","key":"29_CR101","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","volume":"18","author":"L Zhang","year":"2013","unstructured":"Zhang L, Pan J, Dong Y, Tweardy DJ, Dong Y, Garibotto G, Mitch WE (2013) Stat3 activation links a C\/EBPdelta to myostatin pathway to stimulate loss of muscle mass. Cell Metab 18(3):368\u2013379. \nhttps:\/\/doi.org\/10.1016\/j.cmet.2013.07.012","journal-title":"Cell Metab"},{"issue":"2","key":"29_CR102","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","volume":"35","author":"MS Beg","year":"2017","unstructured":"Beg MS, Brenner AJ, Sachdev J, Borad M, Kang YK, Stoudemire J, Smith S, Bader AG, Kim S, Hong DS (2017) Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Investig New Drugs 35(2):180\u2013188. \nhttps:\/\/doi.org\/10.1007\/s10637-016-0407-y","journal-title":"Investig New Drugs"},{"key":"29_CR103","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/abr.abr_214_16","volume":"7","author":"M Simonian","year":"2018","unstructured":"Simonian M, Sharifi M, Nedaeinia R, Mosallaie M, Khosravi S, Avan A, Ghayour-Mobarhan M, Bagheri H, Salehi R (2018) Evaluation of miR-21 inhibition and its impact on cancer susceptibility candidate 2 long noncoding RNA in colorectal cancer cell line. Adv Biomed Res 7:14. \nhttps:\/\/doi.org\/10.4103\/abr.abr_214_16","journal-title":"Adv Biomed Res"},{"key":"29_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.46","volume":"2","author":"KA Lennox","year":"2013","unstructured":"Lennox KA, Owczarzy R, Thomas DM, Walder JA, Behlke MA (2013) Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier. Mol Ther Nucleic Acids 2:e117. \nhttps:\/\/doi.org\/10.1038\/mtna.2013.46","journal-title":"Mol Ther Nucleic Acids"},{"issue":"326","key":"29_CR105","doi-asserted-by":"publisher","first-page":"326ra322","DOI":"10.1126\/scitranslmed.aaf1475","volume":"8","author":"J Viereck","year":"2016","unstructured":"Viereck J, Kumarswamy R, Foinquinos A, Xiao K, Avramopoulos P, Kunz M, Dittrich M, Maetzig T, Zimmer K, Remke J, Just A, Fendrich J, Scherf K, Bolesani E, Schambach A, Weidemann F, Zweigerdt R, de Windt LJ, Engelhardt S, Dandekar T, Batkai S, Thum T (2016) Long noncoding RNA Chast promotes cardiac remodeling. Sci Transl Med 8(326):326ra322. \nhttps:\/\/doi.org\/10.1126\/scitranslmed.aaf1475","journal-title":"Sci Transl Med"},{"issue":"5","key":"29_CR106","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCRESAHA.117.310624","volume":"121","author":"MT Piccoli","year":"2017","unstructured":"Piccoli MT, Gupta SK, Viereck J, Foinquinos A, Samolovac S, Kramer FL, Garg A, Remke J, Zimmer K, Batkai S, Thum T (2017) Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction. Circ Res 121(5):575\u2013583. \nhttps:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310624","journal-title":"Circ Res"},{"key":"29_CR107","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.omtn.2017.06.012","volume":"8","author":"HM Pendergraff","year":"2017","unstructured":"Pendergraff HM, Krishnamurthy PM, Debacker AJ, Moazami MP, Sharma VK, Niitsoo L, Yu Y, Tan YN, Haitchi HM, Watts JK (2017) Locked nucleic acid gapmers and conjugates potently silence ADAM33, an asthma-associated metalloprotease with nuclear-localized mRNA. Mol Ther Nucleic Acids 8:158\u2013168. \nhttps:\/\/doi.org\/10.1016\/j.omtn.2017.06.012","journal-title":"Mol Ther Nucleic Acids"},{"key":"29_CR108","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-213X-11-34","volume":"11","author":"A Koutsoulidou","year":"2011","unstructured":"Koutsoulidou A, Mastroyiannopoulos NP, Furling D, Uney JB, Phylactou LA (2011) Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev Biol 11:34. \nhttps:\/\/doi.org\/10.1186\/1471-213X-11-34","journal-title":"BMC Dev Biol"},{"issue":"1","key":"29_CR109","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1038\/s41598-017-07575-0","volume":"7","author":"N Mercatelli","year":"2017","unstructured":"Mercatelli N, Fittipaldi S, De Paola E, Dimauro I, Paronetto MP, Jackson MJ, Caporossi D (2017) MiR-23-TrxR1 as a novel molecular axis in skeletal muscle differentiation. Sci Rep 7(1):7219. \nhttps:\/\/doi.org\/10.1038\/s41598-017-07575-0","journal-title":"Sci Rep"},{"key":"29_CR110","doi-asserted-by":"publisher","first-page":"391306","DOI":"10.1155\/2015\/391306","volume":"2015","author":"E Lozano-Velasco","year":"2015","unstructured":"Lozano-Velasco E, Galiano-Torres J, Jodar-Garcia A, Aranega AE, Franco D (2015) miR-27 and miR-125 distinctly regulate muscle-enriched transcription factors in cardiac and skeletal myocytes. Biomed Res Int 2015:391306. \nhttps:\/\/doi.org\/10.1155\/2015\/391306","journal-title":"Biomed Res Int"},{"issue":"10","key":"29_CR111","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.7150\/ijbs.15496","volume":"12","author":"Y Yu","year":"2016","unstructured":"Yu Y, Li X, Liu L, Chai J, Haijun Z, Chu W, Yin H, Ma L, Duan H, Xiao M (2016) miR-628 promotes burn-induced skeletal muscle atrophy via targeting IRS1. Int J Biol Sci 12(10):1213\u20131224. \nhttps:\/\/doi.org\/10.7150\/ijbs.15496","journal-title":"Int J Biol Sci"},{"issue":"58","key":"29_CR112","doi-asserted-by":"publisher","first-page":"98029","DOI":"10.18632\/oncotarget.20442","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Gao Y, Duan L, Wei S, Liu J, Tian L, Quan J, Zhang Q, Liu J, Yang J (2017) Metformin ameliorates skeletal muscle insulin resistance by inhibiting miR-21 expression in a high-fat dietary rat model. Oncotarget 8(58):98029\u201398039. \nhttps:\/\/doi.org\/10.18632\/oncotarget.20442","journal-title":"Oncotarget"},{"key":"29_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15201","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Chan MC, Yu Y, Bei Y, Chen P, Zhou Q, Cheng L, Chen L, Ziegler O, Rowe GC, Das S, Xiao J (2017) miR-29b contributes to multiple types of muscle atrophy. Nat Commun 8:15201. \nhttps:\/\/doi.org\/10.1038\/ncomms15201","journal-title":"Nat Commun"},{"issue":"23","key":"29_CR114","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1111\/febs.13110","volume":"281","author":"Y Ma","year":"2014","unstructured":"Ma Y, Zhang L, Huang X (2014) Genome modification by CRISPR\/Cas9. FEBS J 281(23):5186\u20135193. \nhttps:\/\/doi.org\/10.1111\/febs.13110","journal-title":"FEBS J"},{"issue":"9","key":"29_CR115","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrg2842","volume":"11","author":"FD Urnov","year":"2010","unstructured":"Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11(9):636\u2013646. \nhttps:\/\/doi.org\/10.1038\/nrg2842","journal-title":"Nat Rev Genet"},{"issue":"1","key":"29_CR116","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3486","volume":"14","author":"JK Joung","year":"2013","unstructured":"Joung JK, Sander JD (2013) TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14(1):49\u201355. \nhttps:\/\/doi.org\/10.1038\/nrm3486","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6121","key":"29_CR117","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome engineering using CRISPR\/Cas systems. Science 339(6121):819\u2013823. \nhttps:\/\/doi.org\/10.1126\/science.1231143","journal-title":"Science"},{"issue":"6121","key":"29_CR118","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM (2013) RNA-guided human genome engineering via Cas9. Science 339(6121):823\u2013826. \nhttps:\/\/doi.org\/10.1126\/science.1232033","journal-title":"Science"},{"key":"29_CR119","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00471","volume":"2","author":"M Jinek","year":"2013","unstructured":"Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J (2013) RNA-programmed genome editing in human cells. elife 2:e00471. \nhttps:\/\/doi.org\/10.7554\/eLife.00471","journal-title":"elife"},{"issue":"6","key":"29_CR120","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2017.11.032","volume":"172","author":"F Hille","year":"2018","unstructured":"Hille F, Richter H, Wong SP, Bratovic M, Ressel S, Charpentier E (2018) The biology of CRISPR-Cas: backward and forward. Cell 172(6):1239\u20131259. \nhttps:\/\/doi.org\/10.1016\/j.cell.2017.11.032","journal-title":"Cell"},{"issue":"7613","key":"29_CR121","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nature.2016.20302","volume":"535","author":"D Cyranoski","year":"2016","unstructured":"Cyranoski D (2016) Chinese scientists to pioneer first human CRISPR trial. Nature 535(7613):476\u2013477. \nhttps:\/\/doi.org\/10.1038\/nature.2016.20302","journal-title":"Nature"},{"issue":"17","key":"29_CR122","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1182\/blood-2013-11-492231","volume":"123","author":"MV Maus","year":"2014","unstructured":"Maus MV, Grupp SA, Porter DL, June CH (2014) Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood 123(17):2625\u20132635. \nhttps:\/\/doi.org\/10.1182\/blood-2013-11-492231","journal-title":"Blood"},{"key":"29_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7413","volume":"6","author":"HK Liao","year":"2015","unstructured":"Liao HK, Gu Y, Diaz A, Marlett J, Takahashi Y, Li M, Suzuki K, Xu R, Hishida T, Chang CJ, Esteban CR, Young J, Izpisua Belmonte JC (2015) Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells. Nat Commun 6:6413. \nhttps:\/\/doi.org\/10.1038\/ncomms7413","journal-title":"Nat Commun"},{"issue":"10","key":"29_CR124","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa1502214","volume":"373","author":"M Claussnitzer","year":"2015","unstructured":"Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C, Glunk V, Sousa IS, Beaudry JL, Puviindran V, Abdennur NA, Liu J, Svensson PA, Hsu YH, Drucker DJ, Mellgren G, Hui CC, Hauner H, Kellis M (2015) FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 373(10):895\u2013907. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1502214","journal-title":"N Engl J Med"},{"key":"29_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/srep31729","volume":"6","author":"Y Bi","year":"2016","unstructured":"Bi Y, Hua Z, Liu X, Hua W, Ren H, Xiao H, Zhang L, Li L, Wang Z, Laible G, Wang Y, Dong F, Zheng X (2016) Isozygous and selectable marker-free MSTN knockout cloned pigs generated by the combined use of CRISPR\/Cas9 and Cre\/LoxP. Sci Rep 6:31729. \nhttps:\/\/doi.org\/10.1038\/srep31729","journal-title":"Sci Rep"},{"key":"29_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/srep29855","volume":"6","author":"R Guo","year":"2016","unstructured":"Guo R, Wan Y, Xu D, Cui L, Deng M, Zhang G, Jia R, Zhou W, Wang Z, Deng K, Huang M, Wang F, Zhang Y (2016) Generation and evaluation of Myostatin knock-out rabbits and goats using CRISPR\/Cas9 system. Sci Rep 6:29855. \nhttps:\/\/doi.org\/10.1038\/srep29855","journal-title":"Sci Rep"},{"key":"29_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/srep25029","volume":"6","author":"Q Lv","year":"2016","unstructured":"Lv Q, Yuan L, Deng J, Chen M, Wang Y, Zeng J, Li Z, Lai L (2016) Efficient generation of myostatin gene mutated rabbit by CRISPR\/Cas9. Sci Rep 6:25029. \nhttps:\/\/doi.org\/10.1038\/srep25029","journal-title":"Sci Rep"},{"key":"29_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/srep16623","volume":"5","author":"K Wang","year":"2015","unstructured":"Wang K, Ouyang H, Xie Z, Yao C, Guo N, Li M, Jiao H, Pang D (2015) Efficient generation of myostatin mutations in pigs using the CRISPR\/Cas9 system. Sci Rep 5:16623. \nhttps:\/\/doi.org\/10.1038\/srep16623","journal-title":"Sci Rep"},{"issue":"8","key":"29_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136690","volume":"10","author":"M Crispo","year":"2015","unstructured":"Crispo M, Mulet AP, Tesson L, Barrera N, Cuadro F, dos Santos-Neto PC, Nguyen TH, Creneguy A, Brusselle L, Anegon I, Menchaca A (2015) Efficient generation of myostatin knock-out sheep using CRISPR\/Cas9 technology and microinjection into zygotes. PLoS One 10(8):e0136690. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0136690","journal-title":"PLoS One"},{"issue":"6","key":"29_CR130","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/jmcb\/mjv061","volume":"7","author":"Q Zou","year":"2015","unstructured":"Zou Q, Wang X, Liu Y, Ouyang Z, Long H, Wei S, Xin J, Zhao B, Lai S, Shen J, Ni Q, Yang H, Zhong H, Li L, Hu M, Zhang Q, Zhou Z, He J, Yan Q, Fan N, Zhao Y, Liu Z, Guo L, Huang J, Zhang G, Ying J, Lai L, Gao X (2015) Generation of gene-target dogs using CRISPR\/Cas9 system. J Mol Cell Biol 7(6):580\u2013583. \nhttps:\/\/doi.org\/10.1093\/jmcb\/mjv061","journal-title":"J Mol Cell Biol"},{"issue":"6","key":"29_CR131","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s11248-017-0044-z","volume":"26","author":"K Wang","year":"2017","unstructured":"Wang K, Tang X, Xie Z, Zou X, Li M, Yuan H, Guo N, Ouyang H, Jiao H, Pang D (2017) CRISPR\/Cas9-mediated knockout of myostatin in Chinese indigenous Erhualian pigs. Transgenic Res 26(6):799\u2013805. \nhttps:\/\/doi.org\/10.1007\/s11248-017-0044-z","journal-title":"Transgenic Res"},{"issue":"1","key":"29_CR132","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/age.12626","volume":"49","author":"X Wang","year":"2018","unstructured":"Wang X, Niu Y, Zhou J, Zhu H, Ma B, Yu H, Yan H, Hua J, Huang X, Qu L, Chen Y (2018) CRISPR\/Cas9-mediated MSTN disruption and heritable mutagenesis in goats causes increased body mass. Anim Genet 49(1):43\u201351. \nhttps:\/\/doi.org\/10.1111\/age.12626","journal-title":"Anim Genet"},{"issue":"11","key":"29_CR133","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/mt.2016.192","volume":"24","author":"Y Wei","year":"2016","unstructured":"Wei Y, Chen Y, Qiu Y, Zhao H, Liu G, Zhang Y, Meng Q, Wu G, Chen Y, Cai X, Wang H, Ying H, Zhou B, Liu M, Li D, Ding Q (2016) Prevention of muscle wasting by CRISPR\/Cas9-mediated disruption of myostatin in vivo. Mol Ther 24(11):1889\u20131891. \nhttps:\/\/doi.org\/10.1038\/mt.2016.192","journal-title":"Mol Ther"},{"issue":"1","key":"29_CR134","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1038\/s41598-018-21122-5","volume":"8","author":"Y Zou","year":"2018","unstructured":"Zou Y, Dong Y, Meng Q, Zhao Y, Li N (2018) Incorporation of a skeletal muscle-specific enhancer in the regulatory region of Igf1 upregulates IGF1 expression and induces skeletal muscle hypertrophy. Sci Rep 8(1):2781. \nhttps:\/\/doi.org\/10.1038\/s41598-018-21122-5","journal-title":"Sci Rep"},{"issue":"10","key":"29_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164640","volume":"11","author":"X Wang","year":"2016","unstructured":"Wang X, Cai B, Zhou J, Zhu H, Niu Y, Ma B, Yu H, Lei A, Yan H, Shen Q, Shi L, Zhao X, Hua J, Huang X, Qu L, Chen Y (2016) Disruption of FGF5 in cashmere goats using CRISPR\/Cas9 results in more secondary hair follicles and longer fibers. PLoS One 11(10):e0164640. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0164640","journal-title":"PLoS One"},{"issue":"2","key":"29_CR136","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/1566523214666140302193709","volume":"14","author":"B Balakrishnan","year":"2014","unstructured":"Balakrishnan B, Jayandharan GR (2014) Basic biology of adeno-associated virus (AAV) vectors used in gene therapy. Curr Gene Ther 14(2):86\u2013100","journal-title":"Curr Gene Ther"},{"issue":"25","key":"29_CR137","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","volume":"365","author":"AC Nathwani","year":"2011","unstructured":"Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC, Chowdary P, Riddell A, Pie AJ, Harrington C, O\u2019Beirne J, Smith K, Pasi J, Glader B, Rustagi P, Ng CY, Kay MA, Zhou J, Spence Y, Morton CL, Allay J, Coleman J, Sleep S, Cunningham JM, Srivastava D, Basner-Tschakarjan E, Mingozzi F, High KA, Gray JT, Reiss UM, Nienhuis AW, Davidoff AM (2011) Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365(25):2357\u20132365. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1108046","journal-title":"N Engl J Med"},{"key":"29_CR138","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2015.07.006","volume":"24","author":"L Lisowski","year":"2015","unstructured":"Lisowski L, Tay SS, Alexander IE (2015) Adeno-associated virus serotypes for gene therapeutics. Curr Opin Pharmacol 24:59\u201367. \nhttps:\/\/doi.org\/10.1016\/j.coph.2015.07.006","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"29_CR139","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/CMR.00008-08","volume":"21","author":"S Daya","year":"2008","unstructured":"Daya S, Berns KI (2008) Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 21(4):583\u2013593. \nhttps:\/\/doi.org\/10.1128\/CMR.00008-08","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"29_CR140","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/14712598.2018.1416089","volume":"18","author":"N Hardcastle","year":"2018","unstructured":"Hardcastle N, Boulis NM, Federici T (2018) AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials. Expert Opin Biol Ther 18(3):293\u2013307. \nhttps:\/\/doi.org\/10.1080\/14712598.2018.1416089","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"29_CR141","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/mt.2008.149","volume":"16","author":"GL Odom","year":"2008","unstructured":"Odom GL, Gregorevic P, Allen JM, Finn E, Chamberlain JS (2008) Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin\/utrophin-deficient mice. Mol Ther 16(9):1539\u20131545. \nhttps:\/\/doi.org\/10.1038\/mt.2008.149","journal-title":"Mol Ther"},{"issue":"11","key":"29_CR142","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1089\/hum.2011.020","volume":"22","author":"T Koo","year":"2011","unstructured":"Koo T, Malerba A, Athanasopoulos T, Trollet C, Boldrin L, Ferry A, Popplewell L, Foster H, Foster K, Dickson G (2011) Delivery of AAV2\/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of alpha1-syntrophin and alpha-dystrobrevin in skeletal muscles of mdx mice. Hum Gene Ther 22(11):1379\u20131388. \nhttps:\/\/doi.org\/10.1089\/hum.2011.020","journal-title":"Hum Gene Ther"},{"issue":"2","key":"29_CR143","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41434-018-0009-8","volume":"25","author":"Mehmet E. Yalvac","year":"2018","unstructured":"Yalvac ME, Amornvit J, Chen L, Shontz KM, Lewis S, Sahenk Z (2018) AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse model. Gene Ther. \nhttps:\/\/doi.org\/10.1038\/s41434-018-0009-8","journal-title":"Gene Therapy"},{"issue":"348","key":"29_CR144","doi-asserted-by":"publisher","first-page":"348ra398","DOI":"10.1126\/scitranslmed.aac4976","volume":"8","author":"CE Winbanks","year":"2016","unstructured":"Winbanks CE, Murphy KT, Bernardo BC, Qian H, Liu Y, Sepulveda PV, Beyer C, Hagg A, Thomson RE, Chen JL, Walton KL, Loveland KL, McMullen JR, Rodgers BD, Harrison CA, Lynch GS, Gregorevic P (2016) Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice. Sci Transl Med 8(348):348ra398. \nhttps:\/\/doi.org\/10.1126\/scitranslmed.aac4976","journal-title":"Sci Transl Med"},{"issue":"3","key":"29_CR145","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1089\/hum.2017.158","volume":"29","author":"Joseph W. Maricelli","year":"2018","unstructured":"Maricelli JW, Bishaw YM, Wang B, Du M, Rodgers BD (2017) Systemic SMAD7 gene therapy increases striated muscle mass and enhances exercise capacity in a dose-dependent manner. Hum Gene Ther. \nhttps:\/\/doi.org\/10.1089\/hum.2017.158","journal-title":"Human Gene Therapy"},{"issue":"10","key":"29_CR146","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/gt.2013.26","volume":"20","author":"S Moimas","year":"2013","unstructured":"Moimas S, Novati F, Ronchi G, Zacchigna S, Fregnan F, Zentilin L, Papa G, Giacca M, Geuna S, Perroteau I, Arnez ZM, Raimondo S (2013) Effect of vascular endothelial growth factor gene therapy on post-traumatic peripheral nerve regeneration and denervation-related muscle atrophy. Gene Ther 20(10):1014\u20131021. \nhttps:\/\/doi.org\/10.1038\/gt.2013.26","journal-title":"Gene Ther"},{"issue":"3","key":"29_CR147","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1172\/JCI43844","volume":"121","author":"SA Goonasekera","year":"2011","unstructured":"Goonasekera SA, Lam CK, Millay DP, Sargent MA, Hajjar RJ, Kranias EG, Molkentin JD (2011) Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. J Clin Invest 121(3):1044\u20131052. \nhttps:\/\/doi.org\/10.1172\/JCI43844","journal-title":"J Clin Invest"},{"key":"29_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/srep23042","volume":"6","author":"A Hagg","year":"2016","unstructured":"Hagg A, Colgan TD, Thomson RE, Qian H, Lynch GS, Gregorevic P (2016) Using AAV vectors expressing the beta2-adrenoceptor or associated Galpha proteins to modulate skeletal muscle mass and muscle fibre size. Sci Rep 6:23042. \nhttps:\/\/doi.org\/10.1038\/srep23042","journal-title":"Sci Rep"},{"issue":"17","key":"29_CR149","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","volume":"377","author":"F Eichler","year":"2017","unstructured":"Eichler F, Duncan C, Musolino PL, Orchard PJ, De Oliveira S, Thrasher AJ, Armant M, Dansereau C, Lund TC, Miller WP, Raymond GV, Sankar R, Shah AJ, Sevin C, Gaspar HB, Gissen P, Amartino H, Bratkovic D, Smith NJC, Paker AM, Shamir E, O\u2019Meara T, Davidson D, Aubourg P, Williams DA (2017) Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med 377(17):1630\u20131638. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1700554","journal-title":"N Engl J Med"},{"issue":"5","key":"29_CR150","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.amjsurg.2018.02.003","volume":"215","author":"Y Wang","year":"2018","unstructured":"Wang Y, Pati S, Schreiber M (2018) Cellular therapies and stem cell applications in trauma. Am J Surg 215(5):963\u2013972. \nhttps:\/\/doi.org\/10.1016\/j.amjsurg.2018.02.003","journal-title":"Am J Surg"},{"key":"29_CR151","doi-asserted-by":"publisher","unstructured":"Rathod R, Surendran H, Battu R, Desai J, Pal R (2018) Induced pluripotent stem cells (iPSC)-derived retinal cells in disease modeling and regenerative medicine. J Chem Neuroanat. \nhttps:\/\/doi.org\/10.1016\/j.jchemneu.2018.02.002","DOI":"10.1016\/j.jchemneu.2018.02.002"},{"key":"29_CR152","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coph.2018.01.005","volume":"39","author":"NG Frangogiannis","year":"2018","unstructured":"Frangogiannis NG (2018) Cell therapy for peripheral artery disease. Curr Opin Pharmacol 39:27\u201334. \nhttps:\/\/doi.org\/10.1016\/j.coph.2018.01.005","journal-title":"Curr Opin Pharmacol"},{"issue":"11","key":"29_CR153","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","volume":"121","author":"V Florea","year":"2017","unstructured":"Florea V, Rieger AC, DiFede DL, El-Khorazaty J, Natsumeda M, Banerjee MN, Tompkins BA, Khan A, Schulman IH, Landin AM, Mushtaq M, Golpanian S, Lowery MH, Byrnes JJ, Hendel RC, Cohen MG, Valasaki K, Pujol MV, Ghersin E, Miki R, Delgado C, Abuzeid F, Vidro-Casiano M, Saltzman RG, DaFonseca D, Caceres LV, Ramdas KN, Mendizabal A, Heldman AW, Mitrani RD, Hare JM (2017) Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study). Circ Res 121(11):1279\u20131290. \nhttps:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311827","journal-title":"Circ Res"},{"key":"29_CR154","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6487812","volume":"2018","author":"G Poglajen","year":"2018","unstructured":"Poglajen G, Zemljic G, Frljak S, Cerar A, Androcec V, Sever M, Cernelc P (2018) Stem cell therapy in patients with chronic nonischemic heart failure. Stem Cells Int 2018:6487812. \nhttps:\/\/doi.org\/10.1155\/2018\/6487812","journal-title":"Stem Cells Int"},{"issue":"44","key":"29_CR155","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008480","volume":"96","author":"D Fan","year":"2017","unstructured":"Fan D, Wu S, Ye S, Wang W, Guo X, Liu Z (2017) Umbilical cord mesenchyme stem cell local intramuscular injection for treatment of uterine niche: protocol for a prospective, randomized, double-blinded, placebo-controlled clinical trial. Medicine (Baltimore) 96(44):e8480. \nhttps:\/\/doi.org\/10.1097\/MD.0000000000008480","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"29_CR156","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2005.08.021","volume":"122","author":"AJ Wagers","year":"2005","unstructured":"Wagers AJ, Conboy IM (2005) Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122(5):659\u2013667. \nhttps:\/\/doi.org\/10.1016\/j.cell.2005.08.021","journal-title":"Cell"},{"issue":"5","key":"29_CR157","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrm.2016.7","volume":"17","author":"AE Almada","year":"2016","unstructured":"Almada AE, Wagers AJ (2016) Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease. Nat Rev Mol Cell Biol 17(5):267\u2013279. \nhttps:\/\/doi.org\/10.1038\/nrm.2016.7","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5660","key":"29_CR158","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/273306a0","volume":"273","author":"TA Partridge","year":"1978","unstructured":"Partridge TA, Grounds M, Sloper JC (1978) Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 273(5660):306\u2013308","journal-title":"Nature"},{"issue":"6203","key":"29_CR159","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/337176a0","volume":"337","author":"TA Partridge","year":"1989","unstructured":"Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM (1989) Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337(6203):176\u2013179. \nhttps:\/\/doi.org\/10.1038\/337176a0","journal-title":"Nature"},{"issue":"3","key":"29_CR160","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/bies.201200063","volume":"35","author":"CF Bentzinger","year":"2013","unstructured":"Bentzinger CF, Wang YX, von Maltzahn J, Rudnicki MA (2013) The emerging biology of muscle stem cells: implications for cell-based therapies. BioEssays 35(3):231\u2013241. \nhttps:\/\/doi.org\/10.1002\/bies.201200063","journal-title":"BioEssays"},{"issue":"3","key":"29_CR161","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.stemcr.2015.07.016","volume":"5","author":"X Xu","year":"2015","unstructured":"Xu X, Wilschut KJ, Kouklis G, Tian H, Hesse R, Garland C, Sbitany H, Hansen S, Seth R, Knott PD, Hoffman WY, Pomerantz JH (2015) Human satellite cell transplantation and regeneration from diverse skeletal muscles. Stem Cell Reports 5(3):419\u2013434. \nhttps:\/\/doi.org\/10.1016\/j.stemcr.2015.07.016","journal-title":"Stem Cell Reports"},{"issue":"5","key":"29_CR162","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00005-018-0509-7","volume":"66","author":"Aleksandra Klimczak","year":"2018","unstructured":"Klimczak A, Kozlowska U, Kurpisz M (2018) Muscle stem\/progenitor cells and mesenchymal stem cells of bone marrow origin for skeletal muscle regeneration in muscular dystrophies. Arch Immunol Ther Exp (Warsz). \nhttps:\/\/doi.org\/10.1007\/s00005-018-0509-7","journal-title":"Archivum Immunologiae et Therapiae Experimentalis"},{"issue":"1","key":"29_CR163","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5966\/sctm.2014-0060","volume":"4","author":"SE Berry","year":"2015","unstructured":"Berry SE (2015) Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions. Stem Cells Transl Med 4(1):91\u201398. \nhttps:\/\/doi.org\/10.5966\/sctm.2014-0060","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"29_CR164","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.bbrc.2017.09.103","volume":"493","author":"T Hosoyama","year":"2017","unstructured":"Hosoyama T, Ichida S, Kanno M, Ishihara R, Hatashima T, Ueno K, Hamano K (2017) Microgravity influences maintenance of the human muscle stem\/progenitor cell pool. Biochem Biophys Res Commun 493(2):998\u20131003. \nhttps:\/\/doi.org\/10.1016\/j.bbrc.2017.09.103","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"29_CR165","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1161\/CIRCRESAHA.113.300203","volume":"113","author":"O Cappellari","year":"2013","unstructured":"Cappellari O, Cossu G (2013) Pericytes in development and pathology of skeletal muscle. Circ Res 113(3):341\u2013347. \nhttps:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300203","journal-title":"Circ Res"},{"issue":"4","key":"29_CR166","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1091\/mbc.E06-08-0693","volume":"18","author":"C Christov","year":"2007","unstructured":"Christov C, Chretien F, Abou-Khalil R, Bassez G, Vallet G, Authier FJ, Bassaglia Y, Shinin V, Tajbakhsh S, Chazaud B, Gherardi RK (2007) Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell 18(4):1397\u20131409. \nhttps:\/\/doi.org\/10.1091\/mbc.E06-08-0693","journal-title":"Mol Biol Cell"}],"container-title":["Advances in Experimental Medicine and Biology","Muscle Atrophy"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-1435-3_29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T07:58:33Z","timestamp":1541145513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-1435-3_29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811314346","9789811314353"],"references-count":166,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-1435-3_29","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}